Invesco NASDAQ 100 ETF (QQQM)
- Previous Close
174.26 - Open
173.73 - Bid 170.61 x 2300
- Ask 170.63 x 2300
- Day's Range
169.96 - 173.90 - 52 Week Range
127.47 - 184.88 - Volume
2,815,556 - Avg. Volume
1,870,125 - Net Assets 23.02B
- NAV 170.62
- PE Ratio (TTM) 33.83
- Yield 0.65%
- YTD Daily Total Return 1.43%
- Beta (5Y Monthly) 1.18
- Expense Ratio (net) 0.15%
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq, Inc. (“Nasdaq” or the “index provider”) compiles, maintains and calculates the underlying index, which includes securities of 100 of the largest domestic and international nonfinancial companies listed on The Nasdaq Stock Market LLC based on market capitalization. It is non-diversified.
Invesco
Fund Family
Large Growth
Fund Category
23.02B
Net Assets
2020-10-13
Inception Date
Performance Overview: QQQM
Trailing returns as of 4/19/2024. Category is Large Growth.
People Also Watch
Holdings: QQQM
Top 10 Holdings (46.58% of Total Assets)
Sector Weightings
Recent News: QQQM
Research Reports: QQQM
Analyst Report: ASML Holding N.V.
ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s main clients are TSMC, Samsung, and Intel.
RatingNeutralPrice TargetMPW: Raising target price to $4.00
MEDICAL PROPERTIES TRUST INC has an Investment Rating of SELL; a target price of $4.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice TargetMPW: What does Argus have to say about MPW?
MEDICAL PROPERTIES TRUST INC has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice TargetMPW: What does Argus have to say about MPW?
MEDICAL PROPERTIES TRUST INC has an Investment Rating of SELL; a target price of $3.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of Low; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingBearishPrice Target